| Product Code: ETC9552054 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Companion Diagnostics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Companion Diagnostics Market - Industry Life Cycle |
3.4 Sweden Companion Diagnostics Market - Porter's Five Forces |
3.5 Sweden Companion Diagnostics Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Sweden Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Sweden Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Sweden driving the demand for companion diagnostics. |
4.2.2 Growing adoption of personalized medicine and targeted therapies in the healthcare sector. |
4.2.3 Government initiatives and funding to support the development and adoption of companion diagnostics. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for companion diagnostics may limit market growth. |
4.3.2 High costs associated with companion diagnostics development and testing. |
4.3.3 Limited awareness and understanding of companion diagnostics among healthcare providers and patients. |
5 Sweden Companion Diagnostics Market Trends |
6 Sweden Companion Diagnostics Market, By Types |
6.1 Sweden Companion Diagnostics Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Companion Diagnostics Market Revenues & Volume, By Technology Type, 2021- 2031F |
6.1.3 Sweden Companion Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.4 Sweden Companion Diagnostics Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.1.5 Sweden Companion Diagnostics Market Revenues & Volume, By Next Generation Sequencing (NGS), 2021- 2031F |
6.1.6 Sweden Companion Diagnostics Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.1.7 Sweden Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Sweden Companion Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Sweden Companion Diagnostics Market Revenues & Volume, By Neurology, 2021- 2031F |
6.2.4 Sweden Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Sweden Companion Diagnostics Market Export to Major Countries |
7.2 Sweden Companion Diagnostics Market Imports from Major Countries |
8 Sweden Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of personalized medicine in Sweden. |
8.2 Number of collaborations between diagnostic companies and pharmaceutical companies for companion diagnostics development. |
8.3 Rate of reimbursement for companion diagnostics tests by healthcare payers in Sweden. |
9 Sweden Companion Diagnostics Market - Opportunity Assessment |
9.1 Sweden Companion Diagnostics Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Sweden Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Sweden Companion Diagnostics Market - Competitive Landscape |
10.1 Sweden Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Sweden Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here